Abstract
A Na+-channel blocker, cibenzoline, blocks the delayed rectifier potassium current (I k), but its detailed action on the rapidly activating component (I kr) of I k encoded by the human ether-a-go-go-related gene (HERG) has not been clarified. We examined the effects of cibenzoline on stably expressed HERG current in HEK293 cells recorded by the patch-clamp technique of whole-cell configuration. Cibenzoline blocked HERG current expressed in HEK293 cells with IC50 = 3.7 ± 0.963 µM and Hill coefficient = 0.74 ± 0.12. Voltage-depended activation was shifted in a negative direction by cibenzoline. No block or minor block was induced at test depolarization of −40 to −30 mV, and the block increased with depolarization reaching a plateau at 0 mV without a further increase at positive voltages. Voltage-dependent activation of HERG currents became faster at negative test voltages but there were no changes at positive voltages after cibenzoline. No frequency-dependent block of HERG tail current by cibenzoline after equilibration was noted between 1.33 and 0.2 Hz. Steady-state inactivation of the HERG current was shifted in a negative direction by ∼8 mV but the time constants of fast inactivation were little affected by cibenzoline. Cibenzoline blocks the I kr-like current reconstituted by HERG clone transfection with an IC50 value comparable to therapeutic concentrations. Cibenzoline has a preferential affinity, at least, to the open state of the HERG channel with a rapid access to the binding site.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hiramatsu, M., Wu, LM., Hirano, Y. et al. Block of HERG current expressed in HEK293 cells by the Na+-channel blocker cibenzoline. Heart Vessels 19, 137–143 (2004). https://doi.org/10.1007/s00380-003-0750-8
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00380-003-0750-8